Gilead Stock Jumps 8% After Coronavirus Drug Remdesivir Shows ‘Rapid Recoveries’ In Clinical Trials

The stock was up over 8% on Friday.

Read the full post on Forbes - Healthcare

Sergei Klebnikov, Forbes Staff